Keratoconus - Screening in Patients With Downs Syndrome
1 other identifier
observational
137
1 country
1
Brief Summary
The initial purpose of the study is to determine the true tomographic based age-specific prevalence of keratoconus among Danish patients with Downs Syndrome. If, as expected, the prevalence is sizeable, the next step is to determine the optimal age for screening - considering both sensitivity and specificity as well as the need for early diagnosis in order to preserve a good visual acuity with glasses. Lastly, the overall purpose based on the finding in the study is to evaluate if a tomographic screening program for keratoconus among patients with Downs syndrome is beneficial in Denmark. In addition, a sub-study will further have the purpose to investigate whether patients with Downs syndrome are using optimal correction. With the purpose of generating knowledge about refraction of this specific patient group - independent of whether they are diagnosed with keratoconus or not. The study will invite all persons with a genetic test either prenatal or postnatal showing trisomi 21 / Downs syndrom in Denmark and between the age og 10 and 20 years of age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2025
CompletedFirst Submitted
Initial submission to the registry
April 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 2, 2026
CompletedSeptember 2, 2026
September 1, 2025
9 months
April 28, 2026
August 31, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Corneal tomography
Corneal tomography to determine if the participant has keratoconus or not
Baseline, single time point when the study participants are included in the study
Study Arms (1)
Persons with Trisomi 21 / Downs syndrom, 10-20 years of age
The group is identified based on genetic testing either prenatal or postnatal
Eligibility Criteria
All persons with Downs syndrom in the relevant agegroup living in Denmark will be invited to the study
You may qualify if:
- genetic diagnosis of trisomi 21 / downs syndrome
You may not qualify if:
- inability to have cornea tomography performed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus University Hospital
Aarhus, 8200, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sashia Bennett, MD, PhD
University of Aarhus
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2026
First Posted
September 2, 2026
Study Start
September 15, 2025
Primary Completion
June 1, 2026
Study Completion
June 1, 2026
Last Updated
September 2, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
We are not allowed to shared data on an individual level as per our ethical permission